These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2465301)

  • 1. Substance P: a modulator of neuroendocrine-immune function.
    Payan DG
    Hosp Pract (Off Ed); 1989 Feb; 24(2):67-73, 76, 78-80. PubMed ID: 2465301
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual roles of substance P: modulator of immune and neuroendocrine functions.
    Payan DG; Goetzl EJ
    Ann N Y Acad Sci; 1987; 512():465-75. PubMed ID: 2450505
    [No Abstract]   [Full Text] [Related]  

  • 3. Substance P receptor-dependent responses of leukocytes in pulmonary inflammation.
    Payan DG; Goetzl EJ
    Am Rev Respir Dis; 1987 Dec; 136(6 Pt 2):S39-43. PubMed ID: 2446540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurokinin receptors. The role of substance P in inflammatory processes].
    Hrabec Z; Hrabec E
    Postepy Biochem; 1992; 38(1):28-32. PubMed ID: 1380702
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of substance P on cellular immunity.
    Katsanos GS; Anogeianaki A; Orso C; Tete S; Salini V; Antinolfi PL; Sabatino G
    J Biol Regul Homeost Agents; 2008; 22(2):93-8. PubMed ID: 18597700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides and inflammation: the role of substance P.
    Payan DG
    Annu Rev Med; 1989; 40():341-52. PubMed ID: 2471450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of immunity and hypersensitivity by sensory neuropeptides.
    Payan DG; Levine JD; Goetzl EJ
    J Immunol; 1984 Apr; 132(4):1601-4. PubMed ID: 6199404
    [No Abstract]   [Full Text] [Related]  

  • 8. Substance P and immunoregulation.
    McGillis JP; Organist ML; Payan DG
    Fed Proc; 1987 Jan; 46(1):196-9. PubMed ID: 2433163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immuno-modulatory effects of substance P].
    Zhang WH; Zhu YL
    Sheng Li Ke Xue Jin Zhan; 1992 Apr; 23(2):116-21. PubMed ID: 1384123
    [No Abstract]   [Full Text] [Related]  

  • 10. Substance P activates human eosinophils.
    Raap M; Rüdrich U; Ständer S; Gehring M; Kapp A; Raap U
    Exp Dermatol; 2015 Jul; 24(7):557-9. PubMed ID: 25865137
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of inositol phosphates in the actions of substance P on NK1 receptors in exocrine gland cells.
    Putney JW; Bird GS; Horstman DA; Hughes AR; Menniti FS; Nogimori K; Obie J; Oliver KG; Sugiya H; Takemura H
    Ann N Y Acad Sci; 1991; 632():94-102. PubMed ID: 1719914
    [No Abstract]   [Full Text] [Related]  

  • 12. Bidirectional regulatory circuit between the immune and neuroendocrine systems.
    Cavagnaro J; Lewis RM
    Year Immunol; 1989; 4():241-52. PubMed ID: 2467460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of neuropeptides on neurotransmitter biochemistry in the CNS.
    Vaughan PF
    Cell Mol Biol; 1982; 28(4):369-82. PubMed ID: 6182996
    [No Abstract]   [Full Text] [Related]  

  • 14. Substance P: a regulatory neuropeptide for hematopoiesis and immune functions.
    Rameshwar P
    Clin Immunol Immunopathol; 1997 Nov; 85(2):129-33. PubMed ID: 9344694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Localization and physiologic role of neuropeptides and their receptors--the tachykinin family of substance P, neurokinin A and neurokinin B].
    Kimura S
    Nihon Rinsho; 1990 May; 48(5):962-8. PubMed ID: 1695954
    [No Abstract]   [Full Text] [Related]  

  • 16. Substance P: a late-acting B lymphocyte differentiation cofactor.
    Bost KL; Pascual DW
    Am J Physiol; 1992 Mar; 262(3 Pt 1):C537-45. PubMed ID: 1372476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytes.
    Romagnani S
    Clin Allergy Immunol; 2002; 16():97-124. PubMed ID: 11577561
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurokinin agonists and antagonists.
    Regoli D; Nantel F; Tousignant C; Jukic D; Rouissi N; Rhaleb NE; Télémaque S; Drapeau G; d'Orléans-Juste P
    Ann N Y Acad Sci; 1991; 632():170-83. PubMed ID: 1719863
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substance P: immuno-allergic implications].
    Valencia M; Randazzo L
    Allergol Immunopathol (Madr); 1992; 20(1):3-8. PubMed ID: 1380767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine properties of the immune system.
    Dion LD; Blalock JE
    Adv Biochem Psychopharmacol; 1988; 44():15-20. PubMed ID: 2899947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.